Clinical Trials Directory

Trials / Sponsors / Facet Biotech

Facet Biotech

Industry · 17 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects Wi
Hypertension
Phase 22007-09-01
TerminatedA Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial
Ovarian Cancer, Peritoneal Neoplasms
Phase 22007-08-01
CompletedPhase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma
Multiple Myeloma
Phase 12006-12-01
TerminatedStudy of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previou
Ulcerative Colitis
Phase 2 / Phase 32006-08-01
TerminatedA Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Ulcerative Colitis
Phase 2 / Phase 32006-02-01
CompletedVisilizumab for Treatment of Perianal Fistulas in Crohn's Disease
Crohn's Disease
Phase 22005-02-01
CompletedVisilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
Crohn's Disease
Phase 22005-02-01
CompletedUlcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
Severe Ulcerative Colitis
Phase 1 / Phase 22004-01-01
CompletedHumanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Ulcerative Colitis, Gastrointestinal Disease, Inflammatory Bowel Disease
Phase 22003-04-01
CompletedResearch Study of Visilizumab for Treatment of Acute Graft Versus Host Disease
Graft vs Host Disease
Phase 1 / Phase 22002-03-01
CompletedResearch Study in Patients With Severe Ulcerative Colitis
Ulcerative Colitis
Phase 2 / Phase 32002-03-01
CompletedA Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease
Crohn's Disease, Colitis, Intestinal Disease
Phase 22002-03-01
CompletedStudy of Daclizumab in Patients With Chronic, Persistent Asthma
Asthma
Phase 22001-09-01
CompletedPilot Study in Patients With Symptomatic Steroid-Naive Asthma
Asthma
Phase 22001-08-01
UnknownCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or R
Leukemia
Phase 32000-03-01
WithdrawnA Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Heart Failure, Congestive
Phase 1
WithdrawnA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Int
Intravenous Steroid-Refractory Ulcerative Colitis
Phase 3